switching between glp-1 agonists ada GLP‐1 receptor in clinical practice: Expert consensus and practical guidance - Jain - 2021 - International Journal of Clinical Practice Glucagon-Like Peptide-1 Receptor Agonist Use

Given the benefits of rapid diffusion, favorable blood-brain barrier permeability and versatile administration routes, these small molecule compounds will be one of the important candidates of GLP-1RA

These medications primarily function by enhancing insulin secretion

Todd, RD, CSCS, EP-C, CISSN Medical Reviewer Karen E

Future studies will be crucial in addressing existing challenges, optimizing dosing regimens, and expanding their applications to maximize their impact on patient care

124 Whilst there have been suggestions of a potential association with intestinal obstruction, 125 a Danish health registry analysis of 4430 patients with IBD found no increased risk of bowel obstruction or ileus associated with GLP-1RA